SEC Info - Olds Donald - ‘3’ for 4/1/20 re: Acasti Pharma Inc.

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Olds Donald

(Last)

(First)

(Middle)

545 PROMENADE DU CENTROPOLIS

SUITE 100

(Street)

LAVAL

H7T 0A3

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
4/1/20

3. Issuer Name and Ticker or Trading Symbol
Acasti Pharma Inc. [ ACST ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	38,000	I	Ofra Aslan (Spouse) ⁽⁶⁾

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Share Option (Right to Buy)	⁽¹⁾	7/2/28	Common Shares	50,000	0.77 ⁽⁵⁾	D
Share Option (Right to Buy)	⁽²⁾	4/15/29	Common Shares	11,800	1.28 ⁽⁵⁾	D
Share Option (Right to Buy)	⁽³⁾	4/15/29	Common Shares	40,400	1.28 ⁽⁵⁾	D
Share Option (Right to Buy)	⁽⁴⁾	3/31/30	Common Shares	86,000	0.53 ⁽⁵⁾	D

Explanation of Responses:

(1) Represents 50,000 common shares underlying 50,000 share options granted on July 2, 2018. These share options vested in 6 equal installments on a quarterly basis starting from July 2, 2018 until January 2, 2020.

(2) Represents 11,800 common shares underlying 11,800 share options granted on April 15, 2019. These share options vest in 6 equal installments on a quarterly basis starting from April 15, 2019 until October 15, 2020.

(3) Represents 40,400 common shares underlying 40,400 share options granted on April 15, 2019. These share options vest in 6 equal installments on a quarterly basis starting from April 15, 2019 until October 15, 2020.

(4) Represents 86,000 common shares underlying 86,000 share options granted on March 31, 2020. These share options vest in 12 equal installments on a monthly basis starting from March 31, 2020 until March 31, 2021.

(5) Canadian dollars.

(6) 38,000 common shares held by Mr. Olds' wife, Ofra Aslan. Mr. Olds disclaims beneficial ownership of the common shares held by his wife and this report shall not be deemed an admission that Mr. Olds is a beneficial owner of such for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

	/s/ Kelsey Weiner, Attorney-in-Fact	4/1/20
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Olds Donald – ‘3’ for 4/1/20 re: Acasti Pharma Inc.

On: Wednesday, 4/1/20, at 4:21pm ET · For: 4/1/20 · Accession #: 1171843-20-2263 · File #: 1-35776

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents

‘3’ — Initial Statement of Beneficial Ownership of Securities by an Insider — ownership.xml/2.6

This ‘3’ Document is an XML Data File that may be rendered in various formats:

Olds Donald – ‘3’ for 4/1/20 re: Acasti Pharma Inc.

On: Wednesday, 4/1/20, at 4:21pm ET · For: 4/1/20 · Accession #: 1171843-20-2263 · File #: 1-35776

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34Filing Table of Contents

‘3’ — Initial Statement of Beneficial Ownership of Securities by an Insider — ownership.xml/2.6

This ‘3’ Document is an XML Data File that may be rendered in various formats:

Initial Statement of Beneficial Ownership of Securities by an Insider — Form 3 — SEA’34
Filing Table of Contents